Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End Use (Medical Use, Recreational Use, Industrial Use), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Legal Cannabis Market Growth & Trends
The global legal cannabis market size is expected to reach USD 134.4 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 25.3% from 2022 to 2030. The increased legalization across different nations of the usage of cannabis-derived products has gained a lot of popularity. Medical cannabis-based has been used in the treatment of various indications like epileptic seizures, nausea related to chemotherapy, anxiety, and other brain-related diseases. Several studies are being conducted for CBD products in various indications. The medical fraternity has slowly increased acceptance of medical cannabis as well as marijuana and its derivatives owing to its legalization by the governments. Some countries like Canada, the U.S., and Uruguay have legalized its recreational use along with medicinal use. Adult use and recreational use of marijuana is readily available in some of the countries’ markets, thereby increasing adoption and market growth. The COVID-19 pandemic has impeded the growth of the market. Supply chain disruptions and a surge in panic buying scenarios led to the increase in the demand-supply gap, thereby affecting the market growth. However, it is expected to grow post-pandemic with the increased support from governments and ever-increasing demand.
Based on source, the marijuana segment accounted for the largest revenue share of over 70.0% in 2021 and is expected to exhibit the fastest growth rate during the forecast period. Marijuana is easily available and consumers are becoming more aware of its therapeutic properties alongside the more traditional recreational uses. It has been seen to reduce stress and relieve pain, thereby improving sleep irregularities. The decriminalization and legalization of marijuana usage have resulted in a marked reduction in illegal activities surrounding marijuana. CBD is quite potent when it comes to derivatives of the cannabis plant, thus it has emerged as the largest derivative segment with a revenue share of over 65.0% in 2021. The adoption of CBD-based products is increasing rapidly owing to the non-psychoactive nature of the derivative, thereby fueling market growth. In addition, positive attitudes of the medical fraternity toward CBD-based medicines are further propelling the segment growth. In addition, the others
segment is anticipated to grow at the fastest rate during the forecast period owing to rising awareness and acceptance regarding the derivatives, along with increasing geographies sanctioning the use of various cannabinoids for medical and other purposes.
North America dominated the market with a revenue share of over 65.0% in 2021 owing to increasing acceptance of cannabis for medical purposes across the region and changing consumer perception toward cannabis. In addition, the presence of prominent cannabis companies in the North American region is boosting the market growth. Moreover, the Asia region is anticipated to grow at the fastest rate owing to the increasing number of countries sanctioning the use of cannabis, mainly for medical purposes.
Legal Cannabis Market Report Highlights
Legal Cannabis Market Growth & Trends
The global legal cannabis market size is expected to reach USD 134.4 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 25.3% from 2022 to 2030. The increased legalization across different nations of the usage of cannabis-derived products has gained a lot of popularity. Medical cannabis-based has been used in the treatment of various indications like epileptic seizures, nausea related to chemotherapy, anxiety, and other brain-related diseases. Several studies are being conducted for CBD products in various indications. The medical fraternity has slowly increased acceptance of medical cannabis as well as marijuana and its derivatives owing to its legalization by the governments. Some countries like Canada, the U.S., and Uruguay have legalized its recreational use along with medicinal use. Adult use and recreational use of marijuana is readily available in some of the countries’ markets, thereby increasing adoption and market growth. The COVID-19 pandemic has impeded the growth of the market. Supply chain disruptions and a surge in panic buying scenarios led to the increase in the demand-supply gap, thereby affecting the market growth. However, it is expected to grow post-pandemic with the increased support from governments and ever-increasing demand.
Based on source, the marijuana segment accounted for the largest revenue share of over 70.0% in 2021 and is expected to exhibit the fastest growth rate during the forecast period. Marijuana is easily available and consumers are becoming more aware of its therapeutic properties alongside the more traditional recreational uses. It has been seen to reduce stress and relieve pain, thereby improving sleep irregularities. The decriminalization and legalization of marijuana usage have resulted in a marked reduction in illegal activities surrounding marijuana. CBD is quite potent when it comes to derivatives of the cannabis plant, thus it has emerged as the largest derivative segment with a revenue share of over 65.0% in 2021. The adoption of CBD-based products is increasing rapidly owing to the non-psychoactive nature of the derivative, thereby fueling market growth. In addition, positive attitudes of the medical fraternity toward CBD-based medicines are further propelling the segment growth. In addition, the others
segment is anticipated to grow at the fastest rate during the forecast period owing to rising awareness and acceptance regarding the derivatives, along with increasing geographies sanctioning the use of various cannabinoids for medical and other purposes.
North America dominated the market with a revenue share of over 65.0% in 2021 owing to increasing acceptance of cannabis for medical purposes across the region and changing consumer perception toward cannabis. In addition, the presence of prominent cannabis companies in the North American region is boosting the market growth. Moreover, the Asia region is anticipated to grow at the fastest rate owing to the increasing number of countries sanctioning the use of cannabis, mainly for medical purposes.
Legal Cannabis Market Report Highlights
- The market growth can be attributed to the increasing legalization of cannabis across the globe
- The marijuana source segment dominated the market in 2021 owing to the increasing adoption of marijuana for medical as well as adult use
- The CBD derivative segment dominated the market in 2021 owing to the increasing number of countries sanctioning the use of CBD for medical as well as other purposes
- By end use, the medical use segment dominated the market in 2021 owing to the rising geriatric population and increasing demand for cannabis for various medical purposes such as the management of chronic pain, mental disorders, chemotherapy-induced nausea and vomiting, and neurological disorders
- North America dominated the market in 2021 owing to the growing demand and positive attitude toward cannabis in this region
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Process
1.2 Information Procurement
1.2.1 Purchased database:
1.2.1.1 GVR’s internal database
1.2.2 Market Formulation & Validation
1.3 Research Methodology
1.4 Research Scope and Assumptions
1.5 Research Methodology
1.5.1 Region Market: Cagr Calculation
1.5.2 Region Based Segment Share Calculation
1.6 List to Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Legal Cannabis Market Snapshot
CHAPTER 3 GLOBAL LEGAL CANNABIS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Global Legal Cannabis Industry: History Of Medical Use Of Cannabis
3.5 Global Legal Cannabis Industry: History Of Industrial Use Of Cannabis
3.6 Global Legal Cannabis Industry: Number Of Clinical Trials, By Region
3.7 Global Legal Cannabis Industry: Legalization Timeline
3.7.1 Legalization Landscape (Timeline)
3.7.2 U.S. Legalization Landscape
3.7.3 Global Legal Cannabis Regulatory Scenario, By Country
3.7.3.1 U.S.
3.7.3.1.1 Overview
3.7.3.1.2 Cultivation/Production
3.7.3.1.3 Regulatory Bodies Involved
3.7.3.2 Canada
3.7.3.2.1 Overview
3.7.3.2.2 Cultivation/Production
3.7.3.2.3 Regulatory Bodies Involved
3.7.3.3 Germany
3.7.3.3.1 Overview
3.7.3.3.2 Cultivation/Production
3.7.3.3.3 Regulatory Bodies Involved
3.7.3.4 Italy
3.7.3.4.1 Overview
3.7.3.4.2 Cultivation/Production
3.7.3.4.3 Regulatory Bodies Involved
3.7.3.5 Croatia
3.7.3.5.1 Overview
3.7.3.5.2 Cultivation/Production
3.7.3.5.3 Regulatory Bodies Involved
3.7.3.6 The Netherlands
3.7.3.6.1 Overview
3.7.3.6.2 Cultivation/Production
3.7.3.6.3 Regulatory Bodies Involved
3.7.3.7 Czech Republic
3.7.3.7.1 Overview
3.7.3.7.2 Cultivation/Production
3.7.3.7.3 Regulatory Bodies Involved
3.7.3.8 Poland
3.7.3.8.1 Overview
3.7.3.8.2 Cultivation/Production
3.7.3.8.3 Regulatory Bodies Involved
3.7.3.9 Switzerland
3.7.3.9.1 Overview
3.7.3.9.2 Cultivation/Production
3.7.3.9.3 Regulatory Bodies Involved
3.7.3.10 Australia
3.7.3.10.1 Overview
3.7.3.10.2 Cultivation/Production
3.7.3.10.3 Regulatory Bodies Involved
3.7.3.11 Ururguay
3.7.3.11.1 Overview
3.7.3.11.2 Cultivation/Production
3.7.3.11.3 Regulatory Bodies Involved
3.7.3.12 Colombia
3.7.3.12.1 Overview
3.7.3.12.2 Cultivation/Production
3.7.3.12.3 Regulatory Bodies Involved
3.7.3.13 Argentina
3.7.3.13.1 Overview
3.7.3.13.2 Cultivation/Production
3.7.3.13.3 Regulatory Bodies Involved
3.7.3.14 Chile
3.7.3.14.1 Overview
3.7.3.14.2 Cultivation/Production
3.7.3.14.3 Regulatory Bodies Involved
3.7.3.15 Mexico
3.7.3.15.1 Overview
3.7.3.15.2 Cultivation/Production
3.7.3.15.3 Regulatory Bodies Involved
3.7.3.16 Israel
3.7.3.16.1 Overview
3.7.3.16.2 Cultivation/Production
3.7.3.16.3 Regulatory Bodies Involved
3.8 Global Legal Cannabis Industry: Consumption Pattern Analysis, By Region
3.8.1 Consumption Pattern Analysis, By Region
3.8.1.1 North America
3.8.1.2 Europe
3.8.1.3 Asia Pacific
3.8.1.4 Latin America
3.8.1.5 Mea
3.8.2 Estimated Number Of Cannabis Users From 2016 To 2026, By Country
3.8.3 Estimated Number Of Medical Marijuana Users From 2016 To 2026, By Country
3.9 Global Legal Cannabis Industry: Potential Trade Opportunity
3.9.1 Trade Opportunity Analysis, By Region
3.9.1.1 North America
3.9.1.2 Europe
3.9.1.3 Asia Pacific
3.9.1.4 Latin America
3.9.1.5 Mea
3.9.2 Global Legal Cannabis Trade Route
3.9.3 Global Hemp Trade Route
3.9.4 Countries Importing And Exporting Medical Cannabis (Flower)
3.9.5 Countries Importing And Exporting Hemp Seeds
3.9.6 Countries Importing And Exporting Hemp Seed Oil
3.10 Global Legal Cannabis Industry: Seed To Shelf Story
3.10.1 Section Description
3.10.1.1 Cultivators And Growers
3.10.1.2 Manufacturers And Producers
3.10.1.3 Testers
3.10.1.4 Wholesalers And Distributors
3.10.1.5 Retailers
3.10.2 Supply Chain Analysis
3.10.2.1 Profit Margin Estimation
3.11 Global Legal Cannabis Industry: Country Case Studies
3.11.1 U.S.
3.11.1.1 Legalization Of Cannabis:
3.11.1.2 Reason For Legalization:
3.11.1.3 Scenario After Legalization And Consumer Attitudes:
3.11.1.4 Competitive Landscape Post Legalization:
3.11.2 Canada
3.11.2.1 Legalization Of Cannabis:
3.11.2.2 Reason For Legalization:
3.11.2.3 Scenario After Legalization:
3.11.2.4 Consumer Attitudes Toward Legalization:
3.11.2.5 Competitive Landscape Post Legalization:
3.11.3 Thailand
3.11.3.1 Legalization Of Cannabis:
3.11.3.2 Licensing And Import/Export Scenario As Per Legalization Regulations:
3.11.3.3 Reason For Legalization:
3.11.3.4 Scenario After Legalization:
3.11.3.5 Competitive Landscape Post Legalization:
3.11.4 South Africa
3.11.4.1 Legalization Of Cannabis:
3.11.4.2 Reasons For Legalization:
3.11.4.3 Scenario After Legalization:
3.11.4.4 Competitive Landscape Post Legalization:
3.11.5 Uruguay
3.11.5.1 Legalization Of Cannabis:
3.11.5.2 Reason For Legalization:
3.11.5.3 Scenario After Legalization:
3.11.5.4 Consumer Attitudes Toward Legalization:
3.115.5 Competitive Landscape Post Legalization:
CHAPTER 4 GLOBAL LEGAL CANNABIS MARKET: SOURCE ESTIMATES & TREND ANALYSIS
4.1 Segment Dashboard
4.2 Global Legal Cannabis Market: Source Movement Analysis, (USD Million) 2021 & 2030
4.2.1 Marijuana
4.2.1.1 Marijuana Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.1.2 Flowers
4.2.1.2.1 Flowers Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.1.3 Oil And Tinctures
4.2.1.3.1 Oil And Tinctures Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2 Hemp
4.2.2.1 Hemp Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2.2 Hemp Cbd
4.2.2.2.1 Hemp Cbd Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2.3 Supplements
4.2.2.3.1 Supplements Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2.4 Industrial Hemp
4.2.2.4.1 Industrial Hemp Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 5 GLOBAL LEGAL CANNABIS MARKET: DERIVATIVE ESTIMATES & TREND ANALYSIS
5.1 Segment Dashboard
5.2 Global Legal Cannabis Market: Derivative Movement Analysis, USD Million, 2021 & 2030
5.2.1 Cbd
5.2.1.1 Cbd Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.2.2 Thc
5.2.2.1 Thc Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.2.3 Others
5.2.3.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 6 GLOBAL LEGAL CANNABIS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1 Segment Dashboard
6.2 Global Legal Cannabis Market: End-Use Movement Analysis, USD Million, 2021 & 2030
6.2.1 Medical Use
6.2.1.1 Medical Use Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.2 Cancer
6.2.1.2.1 Cancer Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.3 Chronic Pain
6.2.1.3.1 Chronic Pain Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.4 Depression And Anxiety
6.2.1.4.1 Depression And Anxiety Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.5 Arthritis
6.2.1.5.1 Arthritis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.6 Diabetes
6.2.1.6.1 Diabetes Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.7 Glaucoma
6.2.1.7.1 Glaucoma Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.8 Migraines
6.2.1.8.1 Migraines Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.9 Epilepsy
6.2.1.9.1 Epilepsy Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.10 Multiple Sclerosis
6.2.1.10.1 Multiple Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.11 Aids
6.2.1.11.1 Aids Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.12 Amyotrophic Lateral Sclerosis
6.2.1.12.1 Amyotrophic Lateral Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.13 Alzheimer's
6.2.1.13.1 Alzheimer's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.14 Post Traumatic Stress Disorder (Ptsd)
6.2.1.14.1 Post Traumatic Stress Disorder (Ptsd) Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.15 Parkinson's
6.2.1.15.1 Parkinson's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.16 Tourette’s
6.2.1.16.1 Tourette’s Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.17 Others
6.2.1.17.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.2 Recreational Use
6.2.2.1 Recreational Use Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.3 Industrial Use
6.2.3.1 Industrial Use Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 7 GLOBAL LEGAL CANNABIS MARKET: COMPETITIVE ANALYSIS
7.1 Company Market Position Analysis
7.2 Strategic Framework
CHAPTER 8 GLOBAL LEGAL CANNABIS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS: BY SOURCE, DERIVATIVE, AND END USE
8.1 Regional Market Snapshot
8.2 Global Legal Cannabis Market: Regional Movement Analysis, USD Million, 2021 & 2030, USD Million
8.3 North America
8.3.1 North America Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4 Europe
8.4.1 Europe Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.2 Germany
8.4.2.1 Germany Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.3 Uk
8.4.3.1 Uk Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.4 Italy
8.4.4.1 Italy Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.5 Poland
8.4.5.1 Poland Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.6 Czech Republic
8.4.6.1 Czech Republic Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.7 Switzerland
8.4.7.1 Switzerland Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.8 Croatia
8.4.8.1 Croatia Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.9 Netherlands
8.4.9.1 Netherlands Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.10 Spain
8.4.10.1 Spain Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5 Asia
8.5.1 Asia Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.2 China
8.5.2.1 China Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.3 India
8.5.3.1 India Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.4 Japan
8.5.4.1 Japan Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.5 Thailand
8.5.5.1 Thailand Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.6 Oceania
8.6.1 Oceania Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.6.2 Australia
8.6.2.1 Australia Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.6.3 New Zeland
8.6.3.1 New Zeland Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7 Latin America And The Caribbean
8.7.1 Latin America And Caribbean Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.4 Uruguay
8.7.4.1 Uruguay Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.4 Colombia
8.7.4.1 Colombia Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.8 Africa
8.8.1 Africa Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Company Profiles
9.1.1 CANOPY GROWTH CORPORATION
9.1.1.1 Funding
9.1.1.2 Number of Employees
9.1.1.3 Headquarters
9.1.1.4 Business Model (Product Offerings)
9.1.1.5 Growers, Manufacturers, Retailers
9.1.1.6 Revenue 2020(USD Mn)
9.1.1.7 Net Loss 2020 (USD Mn
9.1.1.8 Valuation (USD Mn)
9.1.1.9 Regions With Commercial Presence
9.1.2 GW PHARMACEUTICALS, PLC
9.1.2.1 Funding
9.1.2.2 Number of Employees
9.1.2.3 Headquarters
9.1.2.4 Business Model (Product Offerings)
9.1.2.5 Growers, Manufacturers, Retailers
9.1.2.6 Revenue 2020(USD Mn)
9.1.2.7 Net Loss 2020 (USD Mn
9.1.2.8 Valuation (USD Mn)
9.1.2.9 Regions With Commercial Presence
9.1.3 AURORA CANNABIS, INC.
9.1.3.1 Funding
9.1.3.2 Number of Employees
9.1.3.3 Headquarters
9.1.3.4 Business Model (Product Offerings)
9.1.3.5 Growers, Manufacturers, Retailers
9.1.3.6 Revenue 2020(USD Mn)
9.1.3.7 Net Loss 2020 (USD Mn
9.1.3.8 Valuation (USD Mn)
9.1.3.9 Regions With Commercial Presence
9.1.4 APHRIA, INC. (PRIOR TO MERGER WITH TILRAY)
9.1.4.1 Funding
9.1.4.2 Headquarters
9.1.4.3 Business Model (Product Offerings)
9.1.4.4 Growers, Manufacturers, Retailers
9.1.4.5 Valuation (USD Mn)
9.1.4.6 Regions With Commercial Presence
9.1.5 CRONOS GROUP
9.1.5.1 Funding
9.1.5.2 Number of Employees
9.1.5.3 Headquarters
9.1.5.4 Business Model (Product Offerings)
9.1.5.5 Growers, Manufacturers, Retailers
9.1.5.6 Revenue 2020(USD Mn)
9.1.5.7 Net Loss 2020 (USD Mn
9.1.5.8 Valuation (USD Mn)
9.1.5.9 Regions With Commercial Presence
9.1.6 TILRAY
9.1.6.1 Funding
9.1.6.2 Number of Employees
9.1.6.3 Headquarters
9.1.6.4 Business Model (Product Offerings)
9.1.6.5 Growers, Manufacturers, Retailers
9.1.6.6 Revenue 2020(USD Mn)
9.1.6.7 Net Loss 2020 (USD Mn
9.1.6.8 Valuation (USD Mn)
9.1.6.9 Regions With Commercial Presence
9.1.7 SUNDIAL GROWERS, INC.
9.1.7.1 Funding
9.1.7.2 Number of Employees
9.1.7.3 Headquarters
9.1.7.4 Business Model (Product Offerings)
9.1.7.5 Growers, Manufacturers, Retailers
9.1.7.6 Revenue 2020(USD Mn)
9.1.7.7 Net Loss 2020 (USD Mn
9.1.7.8 Regions With Commercial Presence
9.1.8 INSYS THERAPEUTICS, INC.
9.1.8.1 Funding
9.1.8.2 Number of Employees
9.1.8.3 Headquarters
9.1.8.4 Business Model (Product Offerings)
9.1.8.5 Growers, Manufacturers, Retailers
9.1.8.6 Revenue 2020(USD Mn)
9.1.8.7 Net Loss 2020 (USD Mn
9.1.8.8 Regions With Commercial Presence
9.1.9 THE SCOTTS COMPANY LLC
9.1.9.1 Number of Employees
9.1.9.2 Headquarters
9.1.9.3 Business Model (Product Offerings)
9.1.9.4 Growers, Manufacturers, Retailers
9.1.9.5 Revenue 2020(USD Mn)
9.1.9.6 Net Loss 2020 (USD Mn
9.1.9.7 Valuation (USD Mn)
9.1.9.8 Regions With Commercial Presence
9.1.10 VIVO CANNABIS INC.,
9.1.10.1 Headquarters
9.1.10.2 Business Model (Product Offerings)
9.1.10.3 Growers, Manufacturers, Retailers
9.1.10.4 Revenue 2020(USD Mn)
9.1.10.5 Net Loss 2020 (USD Mn
9.1.10.6 Valuation (USD Mn)
9.1.10.7 Regions With Commercial Presence
9.1.11 CARA THERAPEUTICS INC.
9.1.11.1 Funding
9.1.11.2 Number of Employees
9.1.11.3 Headquarters
9.1.11.4 Business Model (Product Offerings)
9.1.11.5 Growers, Manufacturers, Retailers
9.1.11.6 Revenue 2020(USD Mn)
9.1.11.7 Net Loss 2020 (USD Mn
9.1.11.8 Valuation (USD Mn)
9.1.11.9 Regions With Commercial Presence
1.1 Research Process
1.2 Information Procurement
1.2.1 Purchased database:
1.2.1.1 GVR’s internal database
1.2.2 Market Formulation & Validation
1.3 Research Methodology
1.4 Research Scope and Assumptions
1.5 Research Methodology
1.5.1 Region Market: Cagr Calculation
1.5.2 Region Based Segment Share Calculation
1.6 List to Data Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Legal Cannabis Market Snapshot
CHAPTER 3 GLOBAL LEGAL CANNABIS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Global Legal Cannabis Industry: History Of Medical Use Of Cannabis
3.5 Global Legal Cannabis Industry: History Of Industrial Use Of Cannabis
3.6 Global Legal Cannabis Industry: Number Of Clinical Trials, By Region
3.7 Global Legal Cannabis Industry: Legalization Timeline
3.7.1 Legalization Landscape (Timeline)
3.7.2 U.S. Legalization Landscape
3.7.3 Global Legal Cannabis Regulatory Scenario, By Country
3.7.3.1 U.S.
3.7.3.1.1 Overview
3.7.3.1.2 Cultivation/Production
3.7.3.1.3 Regulatory Bodies Involved
3.7.3.2 Canada
3.7.3.2.1 Overview
3.7.3.2.2 Cultivation/Production
3.7.3.2.3 Regulatory Bodies Involved
3.7.3.3 Germany
3.7.3.3.1 Overview
3.7.3.3.2 Cultivation/Production
3.7.3.3.3 Regulatory Bodies Involved
3.7.3.4 Italy
3.7.3.4.1 Overview
3.7.3.4.2 Cultivation/Production
3.7.3.4.3 Regulatory Bodies Involved
3.7.3.5 Croatia
3.7.3.5.1 Overview
3.7.3.5.2 Cultivation/Production
3.7.3.5.3 Regulatory Bodies Involved
3.7.3.6 The Netherlands
3.7.3.6.1 Overview
3.7.3.6.2 Cultivation/Production
3.7.3.6.3 Regulatory Bodies Involved
3.7.3.7 Czech Republic
3.7.3.7.1 Overview
3.7.3.7.2 Cultivation/Production
3.7.3.7.3 Regulatory Bodies Involved
3.7.3.8 Poland
3.7.3.8.1 Overview
3.7.3.8.2 Cultivation/Production
3.7.3.8.3 Regulatory Bodies Involved
3.7.3.9 Switzerland
3.7.3.9.1 Overview
3.7.3.9.2 Cultivation/Production
3.7.3.9.3 Regulatory Bodies Involved
3.7.3.10 Australia
3.7.3.10.1 Overview
3.7.3.10.2 Cultivation/Production
3.7.3.10.3 Regulatory Bodies Involved
3.7.3.11 Ururguay
3.7.3.11.1 Overview
3.7.3.11.2 Cultivation/Production
3.7.3.11.3 Regulatory Bodies Involved
3.7.3.12 Colombia
3.7.3.12.1 Overview
3.7.3.12.2 Cultivation/Production
3.7.3.12.3 Regulatory Bodies Involved
3.7.3.13 Argentina
3.7.3.13.1 Overview
3.7.3.13.2 Cultivation/Production
3.7.3.13.3 Regulatory Bodies Involved
3.7.3.14 Chile
3.7.3.14.1 Overview
3.7.3.14.2 Cultivation/Production
3.7.3.14.3 Regulatory Bodies Involved
3.7.3.15 Mexico
3.7.3.15.1 Overview
3.7.3.15.2 Cultivation/Production
3.7.3.15.3 Regulatory Bodies Involved
3.7.3.16 Israel
3.7.3.16.1 Overview
3.7.3.16.2 Cultivation/Production
3.7.3.16.3 Regulatory Bodies Involved
3.8 Global Legal Cannabis Industry: Consumption Pattern Analysis, By Region
3.8.1 Consumption Pattern Analysis, By Region
3.8.1.1 North America
3.8.1.2 Europe
3.8.1.3 Asia Pacific
3.8.1.4 Latin America
3.8.1.5 Mea
3.8.2 Estimated Number Of Cannabis Users From 2016 To 2026, By Country
3.8.3 Estimated Number Of Medical Marijuana Users From 2016 To 2026, By Country
3.9 Global Legal Cannabis Industry: Potential Trade Opportunity
3.9.1 Trade Opportunity Analysis, By Region
3.9.1.1 North America
3.9.1.2 Europe
3.9.1.3 Asia Pacific
3.9.1.4 Latin America
3.9.1.5 Mea
3.9.2 Global Legal Cannabis Trade Route
3.9.3 Global Hemp Trade Route
3.9.4 Countries Importing And Exporting Medical Cannabis (Flower)
3.9.5 Countries Importing And Exporting Hemp Seeds
3.9.6 Countries Importing And Exporting Hemp Seed Oil
3.10 Global Legal Cannabis Industry: Seed To Shelf Story
3.10.1 Section Description
3.10.1.1 Cultivators And Growers
3.10.1.2 Manufacturers And Producers
3.10.1.3 Testers
3.10.1.4 Wholesalers And Distributors
3.10.1.5 Retailers
3.10.2 Supply Chain Analysis
3.10.2.1 Profit Margin Estimation
3.11 Global Legal Cannabis Industry: Country Case Studies
3.11.1 U.S.
3.11.1.1 Legalization Of Cannabis:
3.11.1.2 Reason For Legalization:
3.11.1.3 Scenario After Legalization And Consumer Attitudes:
3.11.1.4 Competitive Landscape Post Legalization:
3.11.2 Canada
3.11.2.1 Legalization Of Cannabis:
3.11.2.2 Reason For Legalization:
3.11.2.3 Scenario After Legalization:
3.11.2.4 Consumer Attitudes Toward Legalization:
3.11.2.5 Competitive Landscape Post Legalization:
3.11.3 Thailand
3.11.3.1 Legalization Of Cannabis:
3.11.3.2 Licensing And Import/Export Scenario As Per Legalization Regulations:
3.11.3.3 Reason For Legalization:
3.11.3.4 Scenario After Legalization:
3.11.3.5 Competitive Landscape Post Legalization:
3.11.4 South Africa
3.11.4.1 Legalization Of Cannabis:
3.11.4.2 Reasons For Legalization:
3.11.4.3 Scenario After Legalization:
3.11.4.4 Competitive Landscape Post Legalization:
3.11.5 Uruguay
3.11.5.1 Legalization Of Cannabis:
3.11.5.2 Reason For Legalization:
3.11.5.3 Scenario After Legalization:
3.11.5.4 Consumer Attitudes Toward Legalization:
3.115.5 Competitive Landscape Post Legalization:
CHAPTER 4 GLOBAL LEGAL CANNABIS MARKET: SOURCE ESTIMATES & TREND ANALYSIS
4.1 Segment Dashboard
4.2 Global Legal Cannabis Market: Source Movement Analysis, (USD Million) 2021 & 2030
4.2.1 Marijuana
4.2.1.1 Marijuana Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.1.2 Flowers
4.2.1.2.1 Flowers Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.1.3 Oil And Tinctures
4.2.1.3.1 Oil And Tinctures Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2 Hemp
4.2.2.1 Hemp Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2.2 Hemp Cbd
4.2.2.2.1 Hemp Cbd Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2.3 Supplements
4.2.2.3.1 Supplements Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.2.2.4 Industrial Hemp
4.2.2.4.1 Industrial Hemp Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 5 GLOBAL LEGAL CANNABIS MARKET: DERIVATIVE ESTIMATES & TREND ANALYSIS
5.1 Segment Dashboard
5.2 Global Legal Cannabis Market: Derivative Movement Analysis, USD Million, 2021 & 2030
5.2.1 Cbd
5.2.1.1 Cbd Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.2.2 Thc
5.2.2.1 Thc Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.2.3 Others
5.2.3.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 6 GLOBAL LEGAL CANNABIS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1 Segment Dashboard
6.2 Global Legal Cannabis Market: End-Use Movement Analysis, USD Million, 2021 & 2030
6.2.1 Medical Use
6.2.1.1 Medical Use Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.2 Cancer
6.2.1.2.1 Cancer Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.3 Chronic Pain
6.2.1.3.1 Chronic Pain Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.4 Depression And Anxiety
6.2.1.4.1 Depression And Anxiety Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.5 Arthritis
6.2.1.5.1 Arthritis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.6 Diabetes
6.2.1.6.1 Diabetes Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.7 Glaucoma
6.2.1.7.1 Glaucoma Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.8 Migraines
6.2.1.8.1 Migraines Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.9 Epilepsy
6.2.1.9.1 Epilepsy Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.10 Multiple Sclerosis
6.2.1.10.1 Multiple Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.11 Aids
6.2.1.11.1 Aids Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.12 Amyotrophic Lateral Sclerosis
6.2.1.12.1 Amyotrophic Lateral Sclerosis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.13 Alzheimer's
6.2.1.13.1 Alzheimer's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.14 Post Traumatic Stress Disorder (Ptsd)
6.2.1.14.1 Post Traumatic Stress Disorder (Ptsd) Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.15 Parkinson's
6.2.1.15.1 Parkinson's Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.16 Tourette’s
6.2.1.16.1 Tourette’s Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.1.17 Others
6.2.1.17.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.2 Recreational Use
6.2.2.1 Recreational Use Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.2.3 Industrial Use
6.2.3.1 Industrial Use Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 7 GLOBAL LEGAL CANNABIS MARKET: COMPETITIVE ANALYSIS
7.1 Company Market Position Analysis
7.2 Strategic Framework
CHAPTER 8 GLOBAL LEGAL CANNABIS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS: BY SOURCE, DERIVATIVE, AND END USE
8.1 Regional Market Snapshot
8.2 Global Legal Cannabis Market: Regional Movement Analysis, USD Million, 2021 & 2030, USD Million
8.3 North America
8.3.1 North America Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4 Europe
8.4.1 Europe Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.2 Germany
8.4.2.1 Germany Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.3 Uk
8.4.3.1 Uk Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.4 Italy
8.4.4.1 Italy Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.5 Poland
8.4.5.1 Poland Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.6 Czech Republic
8.4.6.1 Czech Republic Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.7 Switzerland
8.4.7.1 Switzerland Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.8 Croatia
8.4.8.1 Croatia Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.9 Netherlands
8.4.9.1 Netherlands Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.4.10 Spain
8.4.10.1 Spain Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5 Asia
8.5.1 Asia Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.2 China
8.5.2.1 China Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.3 India
8.5.3.1 India Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.4 Japan
8.5.4.1 Japan Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.5.5 Thailand
8.5.5.1 Thailand Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.6 Oceania
8.6.1 Oceania Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.6.2 Australia
8.6.2.1 Australia Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.6.3 New Zeland
8.6.3.1 New Zeland Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7 Latin America And The Caribbean
8.7.1 Latin America And Caribbean Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.4 Uruguay
8.7.4.1 Uruguay Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.7.4 Colombia
8.7.4.1 Colombia Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
8.8 Africa
8.8.1 Africa Legal Cannabis Market Estimates And Forecasts, 2016 - 2030 (USD Million)
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Company Profiles
9.1.1 CANOPY GROWTH CORPORATION
9.1.1.1 Funding
9.1.1.2 Number of Employees
9.1.1.3 Headquarters
9.1.1.4 Business Model (Product Offerings)
9.1.1.5 Growers, Manufacturers, Retailers
9.1.1.6 Revenue 2020(USD Mn)
9.1.1.7 Net Loss 2020 (USD Mn
9.1.1.8 Valuation (USD Mn)
9.1.1.9 Regions With Commercial Presence
9.1.2 GW PHARMACEUTICALS, PLC
9.1.2.1 Funding
9.1.2.2 Number of Employees
9.1.2.3 Headquarters
9.1.2.4 Business Model (Product Offerings)
9.1.2.5 Growers, Manufacturers, Retailers
9.1.2.6 Revenue 2020(USD Mn)
9.1.2.7 Net Loss 2020 (USD Mn
9.1.2.8 Valuation (USD Mn)
9.1.2.9 Regions With Commercial Presence
9.1.3 AURORA CANNABIS, INC.
9.1.3.1 Funding
9.1.3.2 Number of Employees
9.1.3.3 Headquarters
9.1.3.4 Business Model (Product Offerings)
9.1.3.5 Growers, Manufacturers, Retailers
9.1.3.6 Revenue 2020(USD Mn)
9.1.3.7 Net Loss 2020 (USD Mn
9.1.3.8 Valuation (USD Mn)
9.1.3.9 Regions With Commercial Presence
9.1.4 APHRIA, INC. (PRIOR TO MERGER WITH TILRAY)
9.1.4.1 Funding
9.1.4.2 Headquarters
9.1.4.3 Business Model (Product Offerings)
9.1.4.4 Growers, Manufacturers, Retailers
9.1.4.5 Valuation (USD Mn)
9.1.4.6 Regions With Commercial Presence
9.1.5 CRONOS GROUP
9.1.5.1 Funding
9.1.5.2 Number of Employees
9.1.5.3 Headquarters
9.1.5.4 Business Model (Product Offerings)
9.1.5.5 Growers, Manufacturers, Retailers
9.1.5.6 Revenue 2020(USD Mn)
9.1.5.7 Net Loss 2020 (USD Mn
9.1.5.8 Valuation (USD Mn)
9.1.5.9 Regions With Commercial Presence
9.1.6 TILRAY
9.1.6.1 Funding
9.1.6.2 Number of Employees
9.1.6.3 Headquarters
9.1.6.4 Business Model (Product Offerings)
9.1.6.5 Growers, Manufacturers, Retailers
9.1.6.6 Revenue 2020(USD Mn)
9.1.6.7 Net Loss 2020 (USD Mn
9.1.6.8 Valuation (USD Mn)
9.1.6.9 Regions With Commercial Presence
9.1.7 SUNDIAL GROWERS, INC.
9.1.7.1 Funding
9.1.7.2 Number of Employees
9.1.7.3 Headquarters
9.1.7.4 Business Model (Product Offerings)
9.1.7.5 Growers, Manufacturers, Retailers
9.1.7.6 Revenue 2020(USD Mn)
9.1.7.7 Net Loss 2020 (USD Mn
9.1.7.8 Regions With Commercial Presence
9.1.8 INSYS THERAPEUTICS, INC.
9.1.8.1 Funding
9.1.8.2 Number of Employees
9.1.8.3 Headquarters
9.1.8.4 Business Model (Product Offerings)
9.1.8.5 Growers, Manufacturers, Retailers
9.1.8.6 Revenue 2020(USD Mn)
9.1.8.7 Net Loss 2020 (USD Mn
9.1.8.8 Regions With Commercial Presence
9.1.9 THE SCOTTS COMPANY LLC
9.1.9.1 Number of Employees
9.1.9.2 Headquarters
9.1.9.3 Business Model (Product Offerings)
9.1.9.4 Growers, Manufacturers, Retailers
9.1.9.5 Revenue 2020(USD Mn)
9.1.9.6 Net Loss 2020 (USD Mn
9.1.9.7 Valuation (USD Mn)
9.1.9.8 Regions With Commercial Presence
9.1.10 VIVO CANNABIS INC.,
9.1.10.1 Headquarters
9.1.10.2 Business Model (Product Offerings)
9.1.10.3 Growers, Manufacturers, Retailers
9.1.10.4 Revenue 2020(USD Mn)
9.1.10.5 Net Loss 2020 (USD Mn
9.1.10.6 Valuation (USD Mn)
9.1.10.7 Regions With Commercial Presence
9.1.11 CARA THERAPEUTICS INC.
9.1.11.1 Funding
9.1.11.2 Number of Employees
9.1.11.3 Headquarters
9.1.11.4 Business Model (Product Offerings)
9.1.11.5 Growers, Manufacturers, Retailers
9.1.11.6 Revenue 2020(USD Mn)
9.1.11.7 Net Loss 2020 (USD Mn
9.1.11.8 Valuation (USD Mn)
9.1.11.9 Regions With Commercial Presence
LIST OF TABLES
TABLE 1 List of secondary data sources
TABLE 2 Cannabis user pool analysis, by country, 2016 - 2026 (in thousands) (18+ years)
TABLE 3 Medical marijuana users pool analysis, by country, 2016 - 2026 (in thousands)
TABLE 4 North America legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 5 North America legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 6 North America legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 7 North America hemp market, by product, 2016 - 2030 (USD Million)
TABLE 8 North America legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 9 North America legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 10 North America medical-use market, by a medical condition, 2016 - 2030 (USD Million)
TABLE 11 U.S. legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 12 U.S. legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 13 U.S. hemp market, by product, 2016 - 2030 (USD Million)
TABLE 14 U.S. legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 15 U.S. legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 16 U.S. medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 17 Canada legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 18 Canada legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 19 Canada hemp market, by product, 2016 - 2030 (USD Million)
TABLE 20 Canada legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 21 Canada legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 22 Canada medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 23 Europe legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 24 Europe legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 25 Europe legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 26 Europe hemp market, by product, 2016 - 2030 (USD Million)
TABLE 27 Europe legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 28 Europe legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 29 Europe medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 30 Germany legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 31 Germany legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 32 Germany hemp market, by product, 2016 - 2030 (USD Million)
TABLE 33 Germany legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 34 Germany legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 35 Germany medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 36 U.K. legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 37 U.K. legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 38 U.K. hemp market, by product, 2016 - 2030 (USD Million)
TABLE 39 U.K. legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 40 U.K. legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 41 U.K. medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 42 Italy legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 43 Italy legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 44 Italy hemp market, by product, 2016 - 2030 (USD Million)
TABLE 45 Italy legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 46 Italy legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 47 Italy medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 48 Poland legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 49 Poland legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 50 Poland hemp market, by product, 2016 - 2030 (USD Million)
TABLE 51 Poland legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 52 Poland legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 53 Poland medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 54 Czech Republic legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 55 Czech Republic legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 56 Czech Republic hemp market, by product, 2016 - 2030 (USD Million)
TABLE 57 Czech Republic legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 58 Czech Republic legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 59 Czech Republic medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 60 Switzerland legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 61 Switzerland legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 62 Switzerland hemp market, by product, 2016 - 2030 (USD Million)
TABLE 63 Switzerland legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 64 Switzerland legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 65 Switzerland medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 66 Croatia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 67 Croatia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 68 Croatia hemp market, by product, 2016 - 2030 (USD Million)
TABLE 69 Croatia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 70 Croatia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 71 Croatia medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 72 Netherlands legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 73 Netherlands legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 74 Netherlands hemp market, by product, 2016 - 2030 (USD Million)
TABLE 75 Netherlands legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 76 Netherlands legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 77 Netherlands medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 78 Spain legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 79 Spain legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 80 Spain hemp market, by product, 2016 - 2030 (USD Million)
TABLE 81 Spain legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 82 Spain legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 83 Spain medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 84 Asia legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 85 Asia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 86 Asia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 87 Asia market, by product, 2016 - 2030 (USD Million)
TABLE 88 Asia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 89 Asia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 90 Asia medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 91 China legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 92 China legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 93 China hemp market, by product, 2016 - 2030 (USD Million)
TABLE 94 China legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 95 China legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 96 China medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 97 Japan legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 98 Japan legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 99 Japan hemp market, by product, 2016 - 2030 (USD Million)
TABLE 100 Japan legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 101 Japan legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 102 Japan medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 103 India legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 104 India legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 105 India hemp market, by product, 2016 - 2030 (USD Million)
TABLE 106 India legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 107 India legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 108 India medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 109 Thailand legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 110 Thailand legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 111 Thailand hemp market, by product, 2016 - 2030 (USD Million)
TABLE 112 Thailand legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 113 Thailand legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 114 Thailand medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 115 Oceania legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 116 Oceania legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 117 Oceania legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 118 Oceania hemp market, by product, 2016 - 2030 (USD Million)
TABLE 119 Oceania legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 120 Oceania legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 121 Oceania medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 122 Australia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 123 Australia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 124 Australia hemp market, by product, 2016 - 2030 (USD Million)
TABLE 125 Australia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 126 Australia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 127 Australia medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 128 New Zealand legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 129 New Zealand legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 130 New Zealand hemp market, by product, 2016 - 2030 (USD Million)
TABLE 131 New Zealand legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 132 New Zealand legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 133 New Zealand medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 134 Latin America and Caribbean legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 135 Latin America and Caribbean legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 136 Latin America and Caribbean legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 137 Latin America and Caribbean hemp market, by product, 2016 - 2030 (USD Million)
TABLE 138 Latin America and Caribbean legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 139 Latin America and Caribbean legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 140 Latin America and Caribbean medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 141 Brazil legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 142 Brazil legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 143 Brazil hemp market, by product, 2016 - 2030 (USD Million)
TABLE 144 Brazil legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 145 Brazil legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 146 Brazil medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 147 Mexico legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 148 Mexico legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 149 Mexico hemp market, by product, 2016 - 2030 (USD Million)
TABLE 150 Mexico legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 151 Mexico legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 152 Mexico medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 153 Uruguay legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 154 Uruguay legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 155 Uruguay hemp market, by product, 2016 - 2030 (USD Million)
TABLE 156 Uruguay legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 157 Uruguay legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 158 Uruguay medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 159 Colombia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 160 Colombia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 161 Colombia hemp market, by product, 2016 - 2030 (USD Million)
TABLE 162 Colombia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 163 Colombia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 164 Colombia medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 165 Africa legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 166 Africa legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 167 Africa hemp market, by product, 2016 - 2030 (USD Million)
TABLE 168 Africa legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 169 Africa legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 170 Africa medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 1 List of secondary data sources
TABLE 2 Cannabis user pool analysis, by country, 2016 - 2026 (in thousands) (18+ years)
TABLE 3 Medical marijuana users pool analysis, by country, 2016 - 2026 (in thousands)
TABLE 4 North America legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 5 North America legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 6 North America legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 7 North America hemp market, by product, 2016 - 2030 (USD Million)
TABLE 8 North America legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 9 North America legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 10 North America medical-use market, by a medical condition, 2016 - 2030 (USD Million)
TABLE 11 U.S. legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 12 U.S. legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 13 U.S. hemp market, by product, 2016 - 2030 (USD Million)
TABLE 14 U.S. legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 15 U.S. legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 16 U.S. medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 17 Canada legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 18 Canada legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 19 Canada hemp market, by product, 2016 - 2030 (USD Million)
TABLE 20 Canada legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 21 Canada legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 22 Canada medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 23 Europe legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 24 Europe legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 25 Europe legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 26 Europe hemp market, by product, 2016 - 2030 (USD Million)
TABLE 27 Europe legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 28 Europe legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 29 Europe medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 30 Germany legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 31 Germany legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 32 Germany hemp market, by product, 2016 - 2030 (USD Million)
TABLE 33 Germany legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 34 Germany legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 35 Germany medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 36 U.K. legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 37 U.K. legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 38 U.K. hemp market, by product, 2016 - 2030 (USD Million)
TABLE 39 U.K. legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 40 U.K. legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 41 U.K. medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 42 Italy legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 43 Italy legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 44 Italy hemp market, by product, 2016 - 2030 (USD Million)
TABLE 45 Italy legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 46 Italy legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 47 Italy medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 48 Poland legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 49 Poland legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 50 Poland hemp market, by product, 2016 - 2030 (USD Million)
TABLE 51 Poland legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 52 Poland legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 53 Poland medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 54 Czech Republic legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 55 Czech Republic legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 56 Czech Republic hemp market, by product, 2016 - 2030 (USD Million)
TABLE 57 Czech Republic legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 58 Czech Republic legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 59 Czech Republic medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 60 Switzerland legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 61 Switzerland legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 62 Switzerland hemp market, by product, 2016 - 2030 (USD Million)
TABLE 63 Switzerland legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 64 Switzerland legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 65 Switzerland medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 66 Croatia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 67 Croatia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 68 Croatia hemp market, by product, 2016 - 2030 (USD Million)
TABLE 69 Croatia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 70 Croatia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 71 Croatia medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 72 Netherlands legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 73 Netherlands legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 74 Netherlands hemp market, by product, 2016 - 2030 (USD Million)
TABLE 75 Netherlands legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 76 Netherlands legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 77 Netherlands medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 78 Spain legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 79 Spain legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 80 Spain hemp market, by product, 2016 - 2030 (USD Million)
TABLE 81 Spain legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 82 Spain legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 83 Spain medical-use market, by medical condition, 2016 - 2030 (USD Million
TABLE 84 Asia legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 85 Asia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 86 Asia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 87 Asia market, by product, 2016 - 2030 (USD Million)
TABLE 88 Asia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 89 Asia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 90 Asia medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 91 China legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 92 China legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 93 China hemp market, by product, 2016 - 2030 (USD Million)
TABLE 94 China legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 95 China legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 96 China medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 97 Japan legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 98 Japan legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 99 Japan hemp market, by product, 2016 - 2030 (USD Million)
TABLE 100 Japan legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 101 Japan legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 102 Japan medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 103 India legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 104 India legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 105 India hemp market, by product, 2016 - 2030 (USD Million)
TABLE 106 India legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 107 India legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 108 India medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 109 Thailand legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 110 Thailand legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 111 Thailand hemp market, by product, 2016 - 2030 (USD Million)
TABLE 112 Thailand legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 113 Thailand legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 114 Thailand medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 115 Oceania legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 116 Oceania legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 117 Oceania legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 118 Oceania hemp market, by product, 2016 - 2030 (USD Million)
TABLE 119 Oceania legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 120 Oceania legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 121 Oceania medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 122 Australia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 123 Australia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 124 Australia hemp market, by product, 2016 - 2030 (USD Million)
TABLE 125 Australia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 126 Australia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 127 Australia medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 128 New Zealand legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 129 New Zealand legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 130 New Zealand hemp market, by product, 2016 - 2030 (USD Million)
TABLE 131 New Zealand legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 132 New Zealand legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 133 New Zealand medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 134 Latin America and Caribbean legal cannabis market, by country, 2016 - 2030 (USD Million)
TABLE 135 Latin America and Caribbean legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 136 Latin America and Caribbean legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 137 Latin America and Caribbean hemp market, by product, 2016 - 2030 (USD Million)
TABLE 138 Latin America and Caribbean legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 139 Latin America and Caribbean legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 140 Latin America and Caribbean medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 141 Brazil legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 142 Brazil legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 143 Brazil hemp market, by product, 2016 - 2030 (USD Million)
TABLE 144 Brazil legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 145 Brazil legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 146 Brazil medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 147 Mexico legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 148 Mexico legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 149 Mexico hemp market, by product, 2016 - 2030 (USD Million)
TABLE 150 Mexico legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 151 Mexico legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 152 Mexico medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 153 Uruguay legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 154 Uruguay legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 155 Uruguay hemp market, by product, 2016 - 2030 (USD Million)
TABLE 156 Uruguay legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 157 Uruguay legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 158 Uruguay medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 159 Colombia legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 160 Colombia legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 161 Colombia hemp market, by product, 2016 - 2030 (USD Million)
TABLE 162 Colombia legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 163 Colombia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 164 Colombia medical-use market, by medical condition, 2016 - 2030 (USD Million)
TABLE 165 Africa legal cannabis market, by sources, 2016 - 2030 (USD Million)
TABLE 166 Africa legal marijuana market, by product, 2016 - 2030 (USD Million)
TABLE 167 Africa hemp market, by product, 2016 - 2030 (USD Million)
TABLE 168 Africa legal cannabis market, by derivatives, 2016 - 2030 (USD Million)
TABLE 169 Africa legal cannabis market, by end-use, 2016 - 2030 (USD Million)
TABLE 170 Africa medical-use market, by medical condition, 2016 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Various stages of the research workflow
FIG. 2 Information procurement
FIG. 3 Market Formulation & Validation
FIG. 4 Number of clinical trials, by region
FIG. 5 Number of clinical trials, by medical conditions
FIG. 6 State-wise legalization scenario in the U.S.
FIG. 7 Country-wise legalization scenario in Europe
FIG. 8 Consumption of cannabis oil for oral use
FIG. 9 Percentage of respondents using cannabis edible products and those using products other than edibles
FIG. 10 Cannabis consumers (15 to 64 years) (2019)
FIG. 11 Cannabis users in Asian countries (Millions) (2019)
FIG. 12 Cannabis users in Latin American countries (Millions) (2019)
FIG. 13 Global legal marijuana trade route
FIG. 14 Global hemp trade route
FIG. 15 Supply Chain Network of Hemp Biomass to Industrial applications
FIG. 16 Supply chain network of marijuana plant to marijuana oil
FIG. 17 Global legal cannabis market, source outlook key takeaways (USD Million)
FIG. 18 Global legal cannabis market: source movement analysis, 2021 & 2030 (USD Million)
FIG. 19 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 20 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 21 Oil and tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 22 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 23 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 24 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 25 Industrial Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 26 Global legal cannabis market, derivatives outlook key takeaways (USD Million)
FIG. 27 Global legal cannabis market: derivatives movement analysis, 2021 & 2030 (USD Million)
FIG. 28 CBD market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 29 THC market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 30 Others market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 31 Global legal cannabis market, end use outlook key takeaways (USD Million)
FIG. 32 Global legal cannabis market: end use movement analysis, 2021 & 2030 (USD Million)
FIG. 33 Global legal cannabis market: proportion of hemp and marijuana by end use (%)
FIG. 33 Medical use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 34 Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 35 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 36 Depression and anxiety market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 37 Arthritis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 38 Diabetes market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 39 Glaucoma market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 40 Migraines market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 41 Epilepsy market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 42 Multiple Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 43 AIDS market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 44 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 45 Alzheimer's market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 46 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 47 Parkinson's market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 48 Tourette’s market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 49 Others market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 50 Recreational use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 51 Industrial use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 52 Global legal cannabis market, regional outlook key takeaways (USD Million)
FIG. 53 Global legal cannabis market: regional movement analysis, 2021 & 2030 (USD Million)
FIG. 54 Global legal cannabis market, by revenue and YOY growth
FIG. 55 North America legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 56 U.S. legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 57 Canada legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 58 Europe legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 59 Germany legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 60 UK legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 61 Italy legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 62 Poland legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 63 Czech Republic legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 64 Switzerland legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 65 Croatia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 66 Netherlands legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 67 Spain legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 68 Asia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 69 China legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 70 India legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 71 Japan legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG .72 Oceania legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 73 Australia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 74 New Zealand legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 75 Latin America and Caribbean legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 76 Brazil legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 77 Mexico legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 78 Uruguay legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million))
FIG. 79 Colombia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 80 Africa legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 1 Various stages of the research workflow
FIG. 2 Information procurement
FIG. 3 Market Formulation & Validation
FIG. 4 Number of clinical trials, by region
FIG. 5 Number of clinical trials, by medical conditions
FIG. 6 State-wise legalization scenario in the U.S.
FIG. 7 Country-wise legalization scenario in Europe
FIG. 8 Consumption of cannabis oil for oral use
FIG. 9 Percentage of respondents using cannabis edible products and those using products other than edibles
FIG. 10 Cannabis consumers (15 to 64 years) (2019)
FIG. 11 Cannabis users in Asian countries (Millions) (2019)
FIG. 12 Cannabis users in Latin American countries (Millions) (2019)
FIG. 13 Global legal marijuana trade route
FIG. 14 Global hemp trade route
FIG. 15 Supply Chain Network of Hemp Biomass to Industrial applications
FIG. 16 Supply chain network of marijuana plant to marijuana oil
FIG. 17 Global legal cannabis market, source outlook key takeaways (USD Million)
FIG. 18 Global legal cannabis market: source movement analysis, 2021 & 2030 (USD Million)
FIG. 19 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 20 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 21 Oil and tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 22 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 23 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 24 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 25 Industrial Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 26 Global legal cannabis market, derivatives outlook key takeaways (USD Million)
FIG. 27 Global legal cannabis market: derivatives movement analysis, 2021 & 2030 (USD Million)
FIG. 28 CBD market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 29 THC market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 30 Others market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 31 Global legal cannabis market, end use outlook key takeaways (USD Million)
FIG. 32 Global legal cannabis market: end use movement analysis, 2021 & 2030 (USD Million)
FIG. 33 Global legal cannabis market: proportion of hemp and marijuana by end use (%)
FIG. 33 Medical use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 34 Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 35 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 36 Depression and anxiety market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 37 Arthritis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 38 Diabetes market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 39 Glaucoma market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 40 Migraines market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 41 Epilepsy market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 42 Multiple Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 43 AIDS market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 44 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 45 Alzheimer's market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 46 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 47 Parkinson's market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 48 Tourette’s market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 49 Others market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 50 Recreational use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 51 Industrial use market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 52 Global legal cannabis market, regional outlook key takeaways (USD Million)
FIG. 53 Global legal cannabis market: regional movement analysis, 2021 & 2030 (USD Million)
FIG. 54 Global legal cannabis market, by revenue and YOY growth
FIG. 55 North America legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 56 U.S. legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 57 Canada legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 58 Europe legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 59 Germany legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 60 UK legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 61 Italy legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 62 Poland legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 63 Czech Republic legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 64 Switzerland legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 65 Croatia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 66 Netherlands legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 67 Spain legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 68 Asia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 69 China legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 70 India legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 71 Japan legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG .72 Oceania legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 73 Australia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 74 New Zealand legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 75 Latin America and Caribbean legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 76 Brazil legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 77 Mexico legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 78 Uruguay legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million))
FIG. 79 Colombia legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 80 Africa legal cannabis market estimates and forecasts, 2016 - 2030 (USD Million)
